STOCK TITAN

Longduoduo quarterly revenue falls 97% to $17.6K

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Longduoduo Co Ltd (LDDD) reported revenue of $17,595 for the three months ended September 30, 2026, down 97% from $658,764 a year earlier. Net loss was $474,167, compared with $111,182, and operating cash use was $615,031 versus $374,184. A single agent-sales customer represented 100% of revenue.

Cash and cash equivalents were $1,006,499 at September 30, while working capital was $85,068. Management said existing cash was insufficient to fund operations and obligations over the one-year going-concern assessment period, and concluded substantial doubt exists about the company’s ability to continue as a going concern. It is pursuing new-product sales, expense reductions and potential majority-shareholder support, none assured. The company said its disclosure controls were not effective as of September 30, 2026. It also said its newer gut microbiota-based products have yet to gain significant market traction, with limited market acceptance.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 5 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Major pointRevenue fell 97% to $17,595 for the September 2026 quarter.
  • Major point. Forward-looking: it has not happened yet and may not happen.Going-concern substantial doubt; projected cash resources are insufficient.
  • Moderate pointNet loss was $474,167, compared with $111,182 a year earlier.
  • Moderate pointOperating cash use reached $615,031, versus $374,184 a year earlier.
  • Moderate pointDisclosure controls were ineffective as of September 30, 2026.

Filing Explained

Longduoduo reports that at September 30, 2026, most of the $893,991 recorded as deferred revenue had already been used for operating costs, with $209,375 remaining in prepayments—so customer deposits were already part of its operating funding, not simply an additional cash reserve.

Revenue $17,595 Three months ended September 30, 2026; down 97% from $658,764 in the same 2025 period.
Net loss $474,167 Three months ended September 30, 2026, compared with $111,182 in the same 2025 period.
Net cash used in operating activities $615,031 Three months ended September 30, 2026, compared with $374,184 in the same 2025 period.
Cash and cash equivalents $1,006,499 As of September 30, 2026.
Working capital $85,068 As of September 30, 2026.
Deferred revenue $893,991 As of September 30, 2026.
Customer revenue concentration 100% One customer represented this share of revenue for the three months ended September 30, 2026.
going concern financial
"substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
deferred revenue financial
"$893,991 in deferred revenue recorded on the balance sheet"
Cash a company has already received for goods or services it has promised but not yet delivered; it's recorded as a liability because the company still owes that product, service, or future revenue recognition. For investors, deferred revenue signals upcoming work or deliveries that will convert into reported sales over time and affects short-term obligations, cash flow quality, and how quickly a firm can grow recognized revenue—think of it like prepaid subscriptions or gift cards a business must honor later.
commission revenue financial
"material decline in commission revenue"
working capital financial
"working capital was only $85,068"
Working capital is the money a business has available to cover its daily expenses, like paying bills and buying supplies. It’s like the cash in your wallet that helps you handle everyday costs; having enough ensures the business can operate smoothly without running into money shortages.
valuation allowance financial
"The PRC valuation allowance has increased"
A valuation allowance is a reserve set aside to reduce the value of certain assets on a company's financial records when there is uncertainty about whether they will generate the expected benefits. It acts like a caution sign, indicating that some assets might not be fully recoverable or worth their recorded amount. This matters to investors because it provides a more realistic picture of a company's financial health and potential risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did LDDD report for the September 2026 quarter?

LDDD reported $17,595 in revenue for the three months ended September 30, 2026, down 97% from $658,764 in the same period of 2025. Agent services for one customer accounted for 100% of revenue.

How did customer prepayments affect LDDD’s liquidity?

At September 30, 2026, LDDD reported $893,991 in deferred revenue; management said the majority had been used to cover ongoing operating expenses, leaving $209,375 in prepayments on the balance sheet.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
NONE 0001892316 false Q1 --06-30 2027 0001892316 2026-07-01 2026-09-30 0001892316 2025-07-01 2025-09-30 0001892316 2026-06-30 0001892316 2026-09-30 0001892316 cik0001892316:TianjuMember 2026-09-30 0001892316 cik0001892316:RongbinMember 2026-09-30 0001892316 cik0001892316:ChenghengMember 2026-09-30 0001892316 cik0001892316:QingguoMember 2026-09-30 0001892316 srt:MaximumMember cik0001892316:OneYearToFiveYearBorrowingRateMember 2026-07-01 2026-09-30 0001892316 srt:MinimumMember cik0001892316:OneYearToFiveYearBorrowingRateMember 2026-07-01 2026-09-30 0001892316 srt:MaximumMember 2026-09-30 0001892316 srt:MinimumMember 2026-09-30 0001892316 cik0001892316:RongbinMember 2025-08-20 2025-08-20 0001892316 cik0001892316:OperatingLeaseAgreementMember cik0001892316:RongbinMember 2026-09-01 2026-09-01 0001892316 cik0001892316:RongbinMember 2025-08-20 0001892316 cik0001892316:RongbinMember 2026-07-20 2026-07-20 0001892316 cik0001892316:RongbinMember 2025-07-20 2025-07-20 0001892316 cik0001892316:RongbinMember 2025-07-20 0001892316 cik0001892316:OperatingLeaseAgreementMember cik0001892316:ChenghengMember 2025-08-08 0001892316 cik0001892316:OperatingLeaseAgreementMember cik0001892316:ChenghengMember 2025-08-08 2025-08-08 0001892316 cik0001892316:ChenghengMember 2025-08-08 0001892316 cik0001892316:LongduoduoHealthTechnologyMember 2026-03-11 0001892316 cik0001892316:LongduoduoHealthTechnologyMember 2026-03-11 2026-03-11 0001892316 cik0001892316:LongduoduoHealthTechnologyMember 2025-03-11 2025-03-11 0001892316 cik0001892316:LongduoduoHealthTechnologyMember 2025-03-11 0001892316 cik0001892316:ChenghengMember 2024-11-20 2024-11-20 0001892316 cik0001892316:ChenghengMember 2024-11-20 0001892316 cik0001892316:ChenMingyueMember 2026-09-18 2026-09-18 0001892316 cik0001892316:QingguoMember 2025-09-10 0001892316 2025-09-10 2025-09-10 0001892316 cik0001892316:QingguoMember 2024-08-14 2024-08-14 0001892316 cik0001892316:QingguoMember 2024-08-14 0001892316 cik0001892316:TianjuMember 2024-04-01 2024-04-01 0001892316 cik0001892316:TianjuMember 2024-04-01 0001892316 us-gaap:StateAdministrationOfTaxationChinaMember 2026-07-01 2026-09-30 0001892316 cik0001892316:USFederalMember 2026-07-01 2026-09-30 0001892316 country:US 2025-07-01 2025-09-30 0001892316 country:US 2026-07-01 2026-09-30 0001892316 country:US 2026-09-30 0001892316 country:CN 2025-07-01 2025-09-30 0001892316 country:CN 2026-07-01 2026-09-30 0001892316 country:CN 2026-06-30 0001892316 country:CN 2026-09-30 0001892316 us-gaap:StateAdministrationOfTaxationChinaMember 2025-07-01 2025-09-30 0001892316 country:US us-gaap:DomesticCountryMember 2025-07-01 2025-09-30 0001892316 country:US us-gaap:DomesticCountryMember 2026-07-01 2026-09-30 0001892316 country:HK 2026-07-01 2026-09-30 0001892316 cik0001892316:TaxYear20192020Member country:HK 2026-07-01 2026-09-30 0001892316 cik0001892316:MrZhangLiangMember 2026-07-01 2026-09-30 0001892316 cik0001892316:XuHuiboMember 2026-06-30 0001892316 cik0001892316:XuHuiboMember 2026-09-30 0001892316 cik0001892316:ZhangLiangMember 2026-06-30 0001892316 cik0001892316:ZhangLiangMember 2026-09-30 0001892316 us-gaap:LeaseholdImprovementsMember 2026-06-30 0001892316 us-gaap:LeaseholdImprovementsMember 2026-09-30 0001892316 us-gaap:OfficeEquipmentMember 2026-06-30 0001892316 us-gaap:OfficeEquipmentMember 2026-09-30 0001892316 2024-07-01 2025-06-30 0001892316 us-gaap:SoftwareInDevelopmentMember 2026-09-30 0001892316 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2026-09-30 0001892316 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2026-09-30 0001892316 us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember cik0001892316:SupplierDMember 2026-06-30 0001892316 us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember cik0001892316:SupplierCMember 2026-06-30 0001892316 us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember cik0001892316:SupplierCMember 2026-09-30 0001892316 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember cik0001892316:SupplierBMember 2025-07-01 2025-09-30 0001892316 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember cik0001892316:SupplierAMember 2025-07-01 2025-09-30 0001892316 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember cik0001892316:CustomerMember 2024-07-01 2025-06-30 0001892316 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember cik0001892316:CustomerMember 2026-07-01 2026-09-30 0001892316 2025-06-30 0001892316 currency:USD cik0001892316:RevenueAndExpensesMember 2025-09-30 0001892316 currency:CNY cik0001892316:RevenueAndExpensesMember 2025-09-30 0001892316 currency:USD cik0001892316:RevenueAndExpensesMember 2026-09-30 0001892316 currency:CNY cik0001892316:RevenueAndExpensesMember 2026-09-30 0001892316 currency:USD cik0001892316:AssetsAndLiabilitiesMember 2025-09-30 0001892316 currency:CNY cik0001892316:AssetsAndLiabilitiesMember 2025-09-30 0001892316 currency:USD cik0001892316:AssetsAndLiabilitiesMember 2026-09-30 0001892316 currency:CNY cik0001892316:AssetsAndLiabilitiesMember 2026-09-30 0001892316 cik0001892316:InnerMongoliaTianjuHealthConsultingCompanyLimitedMember 2026-09-30 0001892316 cik0001892316:InnerMongoliaTianjuHealthConsultingCompanyLimitedMember 2026-07-01 2026-09-30 0001892316 cik0001892316:InnerMongoliaChenghengHealthConsultingCompanyLimitedMember 2026-09-30 0001892316 cik0001892316:InnerMongoliaChenghengHealthConsultingCompanyLimitedMember 2026-07-01 2026-09-30 0001892316 cik0001892316:InnerMongoliaRongbinHealthConsultingCompanyLimitedMember 2026-09-30 0001892316 cik0001892316:InnerMongoliaRongbinHealthConsultingCompanyLimitedMember 2026-07-01 2026-09-30 0001892316 cik0001892316:InnerMongoliaQingguoHealthConsultingCompanyLimitedMember 2026-09-30 0001892316 cik0001892316:InnerMongoliaQingguoHealthConsultingCompanyLimitedMember 2026-07-01 2026-09-30 0001892316 cik0001892316:LongduoduoHealthTechnologyCompanyLimitedMember 2026-09-30 0001892316 cik0001892316:LongduoduoHealthTechnologyCompanyLimitedMember 2026-07-01 2026-09-30 0001892316 cik0001892316:BeijingYihuaHealthConsultingCoLimitedYihuaMember 2026-09-30 0001892316 cik0001892316:BeijingYihuaHealthConsultingCoLimitedYihuaMember 2026-07-01 2026-09-30 0001892316 cik0001892316:BeijingJulongHealthConsultingCoLimitedJulongMember 2026-09-30 0001892316 cik0001892316:BeijingJulongHealthConsultingCoLimitedJulongMember 2026-07-01 2026-09-30 0001892316 cik0001892316:LDDJKHongKongLimitedMember 2026-09-30 0001892316 cik0001892316:LDDJKHongKongLimitedMember 2026-07-01 2026-09-30 0001892316 cik0001892316:LDDTechnologyLimitedMember 2026-09-30 0001892316 cik0001892316:LDDTechnologyLimitedMember 2026-07-01 2026-09-30 0001892316 cik0001892316:LDDTechnologyLimitedMember 2025-02-19 0001892316 cik0001892316:LDDTechnologyLimitedMember 2025-02-19 2025-02-19 0001892316 cik0001892316:InnerMongoliaTianjuHealthConsultingCompanyLimitedMember 2021-07-05 0001892316 cik0001892316:InnerMongoliaChenghengHealthConsultingCompanyLimitedMember 2021-04-09 0001892316 cik0001892316:InnerMongoliaRongbinHealthConsultingCompanyLimitedMember 2021-03-18 0001892316 cik0001892316:InnerMongoliaQingguoHealthConsultingCompanyLimitedMember 2020-09-08 0001892316 cik0001892316:LongduoduoHealthTechnologyCompanyLimitedMember 2025-04-02 0001892316 cik0001892316:LongduoduoHealthTechnologyCompanyLimitedMember 2021-08-16 0001892316 cik0001892316:BeijingYihuaHealthConsultingCoLimitedYihuaMember 2025-01-07 0001892316 cik0001892316:BeijingJulongHealthConsultingCoLimitedJulongMember 2024-07-23 0001892316 cik0001892316:LDDJKHongKongLimitedMember 2024-04-09 0001892316 cik0001892316:LongduoduoCompanyLimitedMember 2021-10-26 0001892316 cik0001892316:LongduoduoCompanyLimitedMember 2021-10-26 2021-10-26 0001892316 2025-09-30 0001892316 us-gaap:NoncontrollingInterestMember 2026-09-30 0001892316 us-gaap:ParentMember 2026-09-30 0001892316 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-09-30 0001892316 us-gaap:RetainedEarningsMember 2026-09-30 0001892316 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001892316 us-gaap:CommonStockMember 2026-09-30 0001892316 us-gaap:NoncontrollingInterestMember 2026-07-01 2026-09-30 0001892316 us-gaap:ParentMember 2026-07-01 2026-09-30 0001892316 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-07-01 2026-09-30 0001892316 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001892316 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001892316 us-gaap:NoncontrollingInterestMember 2026-06-30 0001892316 us-gaap:ParentMember 2026-06-30 0001892316 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001892316 us-gaap:RetainedEarningsMember 2026-06-30 0001892316 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001892316 us-gaap:CommonStockMember 2026-06-30 0001892316 us-gaap:NoncontrollingInterestMember 2025-09-30 0001892316 us-gaap:ParentMember 2025-09-30 0001892316 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001892316 us-gaap:RetainedEarningsMember 2025-09-30 0001892316 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001892316 us-gaap:CommonStockMember 2025-09-30 0001892316 us-gaap:NoncontrollingInterestMember 2025-07-01 2025-09-30 0001892316 us-gaap:ParentMember 2025-07-01 2025-09-30 0001892316 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0001892316 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001892316 us-gaap:NoncontrollingInterestMember 2025-06-30 0001892316 us-gaap:ParentMember 2025-06-30 0001892316 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001892316 us-gaap:RetainedEarningsMember 2025-06-30 0001892316 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001892316 us-gaap:CommonStockMember 2025-06-30 0001892316 cik0001892316:CostOfServiceRevenueMember 2025-07-01 2025-09-30 0001892316 cik0001892316:CommissionRevenueMember 2025-07-01 2025-09-30 0001892316 cik0001892316:CommissionRevenueMember 2026-07-01 2026-09-30 0001892316 cik0001892316:ServiceRevenueMember 2025-07-01 2025-09-30 0001892316 cik0001892316:CostOfServiceRevenueMember 2026-07-01 2026-09-30 0001892316 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember cik0001892316:SupplierBMember 2026-07-01 2026-09-30 0001892316 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001892316 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember cik0001892316:SupplierAMember 2026-07-01 2026-09-30 0001892316 us-gaap:SupplierConcentrationRiskMember us-gaap:AccountsPayableMember cik0001892316:SupplierDMember 2026-09-30 0001892316 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001892316 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001892316 cik0001892316:ServiceRevenueMember 2026-07-01 2026-09-30 iso4217:USD xbrli:pure iso4217:USD xbrli:shares xbrli:shares iso4217:CNY utr:sqm iso4217:HKD

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from_____________ to____________

 

Commission File Number: 0-56615

 

LONGDUODUO COMPANY LIMITED

(Exact name of registrant as specified in its charter)

 

Nevada   37-2018431
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification Number)

 

G3-5-8016 Shui’an Town, Ruyi Headquarters Base

Hohhot Economic Development Zone

Inner Mongolia 010000

P.R. China

Office: +86 (0472) 510 4980

(Address, including zip code, and telephone number, including area code,

of Registrant’s principal executive offices)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol   Name of Each Exchange on Which Registered
None   None   Not Applicable

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer  ☐
Non-accelerated filer   ☒   Smaller reporting company  ☒
    Emerging growth company  ☒ 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12 b-2 of the Act).  Yes ☐ No ☒

 

(APPLICABLE ONLY TO CORPORATE REGISTRANTS)

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

As of the date of filing of this report, there were outstanding 30,015,036 shares of the issuer’s common stock, par value $0.001 per share.

 

 

 

 

TABLE OF CONTENTS

 

      Page
  PART I—FINANCIAL INFORMATION   1
Item 1 Financial Statements.   1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.   2
Item 3. Quantitative and Qualitative Disclosures About Market Risk.   5
Item 4. Controls and Procedures.   5
       
  PART II—OTHER INFORMATION   6
Item 1. Legal Proceedings.   6
Item 1A. Risk Factors   6
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.   6
Item 3. Defaults Upon Senior Securities.   6
Item 4. Mine Safety Disclosure   6
Item 5. Other Information.   6
Item 6. Exhibits.   6

 

i

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

 

    Page
     
Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and June 30, 2026   F-1
     
Consolidated Statements of Operations and Comprehensive Loss for the Three Months Ended September 30, 2026 and 2025 (Unaudited)   F-2
     
Consolidated Statements of Changes in Shareholders’ Equity for the Three Months Ended September 30, 2026 and 2025 (Unaudited)   F-3
     
Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2026 and 2025 (Unaudited)   F-4
     
Notes to Consolidated Financial Statements (Unaudited)   F-5 – F-17

 

1

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

    September 30,
2026
    June 30,
2026
 
    (Unaudited)        
Assets            
Current Assets:            
Cash and cash equivalents   $ 1,006,499     $ 1,588,930  
Other receivables     75,060       56,939  
Prepayments     209,375       138,287  
Total current assets     1,290,934       1,784,156  
Property and equipment, net     187,751       213,025  
Right-of-use assets     55,992       66,283  
Total assets   $ 1,534,677     $ 2,063,464  
                 
Liabilities and Equity                
Current Liabilities:                
Accounts payable   $ 232,937     $ 403,477  
Deferred revenue     893,991       790,429  
Accrued expenses     48,727       52,036  
Due to related parties     4,884       3,721  
Operating lease liabilities, current     24,643       24,113  
Other current liabilities     684       8,966  
Total current liabilities     1,205,866       1,282,742  
Operating lease liabilities, less current portion     25,358       24,957  
Total liabilities     1,231,224       1,307,699  
                 
Equity:                
Preferred stock; $0.001 par value, 30,000,000 shares authorized, no shares issued and outstanding at September 30, 2026 and June 30, 2026     -       -  
Common stock; $0.001 par value, 500,000,000 shares authorized; 30,015,036 and 30,015,036 shares issued and outstanding at September 30, 2026 and June 30, 2026     30,015       30,015  
Additional paid-in capital     355,191       7,246,719  
Accumulated deficit     (292,556 )     (6,747,828 )
Accumulated other comprehensive income     195,457       174,785  
Total stockholders’ equity attributable to the common stockholders     288,107       703,691  
Non-controlling interests     15,346       52,074  
Total stockholders’ equity     303,453       755,765  
Total liabilities and equity   $ 1,534,677     $ 2,063,464  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-1

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

 

    For the Three Months Ended
September 30,
 
    2026     2025  
             
Revenues:            
Service revenue   $ -     $ 5,606  
Commission revenue     17,595       653,158  
Total revenues, net     17,595       658,764  
Cost of revenue:                
Cost of service revenue     -       6,710  
Total cost of revenues     -       6,710  
Gross profit     17,595       652,054  
                 
Selling, general and administrative expenses     513,930       736,468  
Loss from operations     (496,335 )     (84,414 )
Other income, net     17,490       40,326  
Loss before provision for income taxes     (478,845 )     (44,088 )
Income tax expense (Benefit)     (4,678 )     67,094  
Net loss     (474,167 )     (111,182 )
Less: net loss attributable to non-controlling interests     (37,205 )     (20,228 )
Net loss attributable to common stockholders   $ (436,962 )   $ (90,954 )
                 
Comprehensive loss:                
Net loss   $ (474,167 )   $ (111,182 )
Foreign currency translation adjustment     21,149       13,886  
Comprehensive loss     (453,018 )     (97,296 )
Less: comprehensive loss attributable to non-controlling interests     (36,728 )     (19,599 )
Comprehensive loss attributable to the common stockholders   $ (416,290 )   $ (77,697 )
                 
Basic and diluted (loss) per share   $ (0.015 )   $ (0.003 )
Weighted average number of shares outstanding -basic and diluted     30,015,036       30,015,036  

 

The accompanying notes are an integral part of these consolidated financial statements. 

 

F-2

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

(UNAUDITED)

 

    Common stock     Additional           Accumulated
Other
    Total     Non-        
    Number of
Shares
    Amount     Paid-in
Capital
    Accumulated
Deficit
    Comprehensive
Income
    Stockholder’
Equity
    controlling
Interests
    Total
Equity
 
Balance at June 30, 2025     30,015,036     $ 30,015     $ 7,246,719     $ (6,169,197 )   $ 77,028     $ 1,184,565     $ 111,467     $ 1,296,032  
Net loss     -       -       -       (90,954 )     -       (90,954 )     (20,228 )     (111,182 )
Foreign currency translation adjustment     -       -       -       -       13,257       13,257       629       13,886  
Balance at September 30, 2025     30,015,036     $ 30,015     $ 7,246,719     $ (6,260,151 )   $ 90,285     $ 1,106,868     $ 91,868     $ 1,198,736  

 

    Common stock     Additional           Accumulated
Other
    Total     Non-        
    Number of
Shares
    Amount     Paid-in
Capital
    Accumulated
Deficit
    Comprehensive
Income
    Stockholder’
Equity
    controlling
Interests
    Total
Equity
 
Balance at June 30, 2026     30,015,036     $ 30,015     $ 7,246,719     $ (6,747,828 )   $ 174,785     $ 703,691     $ 52,074     $ 755,765  
Deregistration of the HK subsidiary     -       -       (6,891,528 )     6,892,234       -       706       -       706  
Net loss     -       -       -       (436,962 )     -       (436,962 )     (37,205 )     (474,167 )
Foreign currency translation adjustment     -       -       -       -       20,672       20,672       477       21,149  
Balance at September 30, 2026     30,015,036     $ 30,015     $ 355,191     $ (292,556 )   $ 195,457     $ 288,107     $ 15,346     $ 303,453  

 

The accompanying notes are an integral part of these consolidated financial statements

 

F-3

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

    For the Three Months Ended
September 30,
 
    2026     2025  
Cash Flows from Operating Activities            
Net loss   $ (474,167 )   $ (111,182 )
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:                
Depreciation & amortization     27,926       27,422  
Deregistration of the HK subsidiary     706       -  
Operating lease expense     11,384       23,604  
Changes in operating assets and liabilities:                
Other receivables     (17,272 )     (41,321 )
Prepayments     (70,187 )     (74,976 )
Due from related parties     -       11,528  
Accounts payable     (174,874 )     (198,897 )
Deferred revenue     92,617       47,189  
Accrued expenses     (3,973 )     (7,888 )
Due to related parties     1,163       (4,209 )
Operating lease     -       (23,752 )
Other current liabilities     (8,354 )     (21,702 )
Net cash used in operating activities     (615,031 )     (374,184 )
                 
Cash Flows from Investing Activities                
Purchase of property, plant and equipment     -       (29,948 )
Net cash used in investing activities     -       (29,948 )
                 
Effect of exchange rate fluctuation on cash and cash equivalents     32,600       8,707  
Net decrease in cash and cash equivalents     (582,431 )     (395,425 )
                 
Cash and cash equivalents, beginning of period     1,588,930       1,642,721  
Cash and cash equivalents, end of period   $ 1,006,499     $ 1,247,296  
                 
Supplemental disclosure of cash flow information                
Cash paid for income taxes, net of refunds received   $ (4,678 )   $ 15,424  
Cash paid for interest expense   $ -     $ -  
                 
Supplemental disclosure of non-cash activities                
Right-of-use assets obtained in exchange for new operating lease liabilities     -       68,874  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

(UNAUDITED)

 

NOTE 1. NATURE OF OPERATIONS AND BASIS OF PRESENTATION

 

Longduoduo Company Limited (“Longduoduo”, together as a group with Longduoduo’s subsidiaries referred to as the “Company” or “we”) was incorporated in the State of Nevada on October 25, 2021. Acting in a principal capacity, the Company provides customers comprehensive and high-quality preventive healthcare & wellness solutions including a wide range of preventive healthcare services and wellness products, including disease screening, healthcare treatment, healthcare products, nutritional products and other services through a network of third-party healthcare service providers. In June 2023, the Company began to engage in agent sales of preventive healthcare & wellness solutions on behalf of a third-party provider and earn commissions revenue.

 

Longduoduo’s subsidiaries include: 

 

  ● Longduoduo Company Limited (Hong Kong) (“Longduoduo HK”), which was established on July 26, 2021 under the laws of Hong Kong. On October 26, 2021, Longduoduo issued 30,000,000 shares of its common stock to the original shareholders of Longduoduo HK, in exchange for 100% of the outstanding shares of Longduoduo HK. On August 28, 2026, Longduoduo HK was officially deregistered.

 

  ● LDD Technology Limited (“LDD”) was established on March 18, 2024 under the laws of British Virgin Islands. On February 19, 2025, Longduoduo issued 10,020 shares of its common stock to the original shareholders of LDD, in exchange for 100% of the outstanding shares of LDD.

 

  ● LDDJK Hong Kong Limited (“LDDJK”) was established on April 9, 2024 under the laws of Hong Kong. LDD has controlled 100% of LDDJK since its inception.

 

  ● Beijing Julong Health Consulting Co., Limited (“Julong”) was established in Beijing, China on July 23, 2024. LDDJK has controlled 100% of Julong since its inception.

 

  ● Beijing Yihua Health Consulting Co., Limited (“Yihua”) was established in Beijing, China on March 14, 2024. On January 7, 2025, Julong acquired all the shares held by the original shareholders of Yihua, and controlled 100% ownership of Yihua.

 

  ● Longduoduo Health Technology Company Limited (“Longduoduo Health Technology”), a privately held Limited Company registered in Inner Mongolia, China on August 20, 2020. On August 16, 2021, Longduoduo HK acquired 100% of the ownership of Longduoduo Health Technology from the original shareholders of Longduoduo Health Technology. On April 2, 2025, Julong acquired 100% of Longduoduo Health Technology from Longduoduo HK.

 

  ● Inner Mongolia Qingguo Health Consulting Company Limited (“Qingguo”), a privately held Limited Company registered in Inner Mongolia, China on June 18, 2020. On September 8, 2020, Longduoduo Health Technology acquired 90% of the ownership of Qingguo from the original shareholders of Qingguo.

 

  ● Inner Mongolia Rongbin Health Consulting Company Limited (“Rongbin”), a privately held Limited Company registered in Inner Mongolia, China on March 18, 2021. Longduoduo Health Technology has controlled 80% of the ownership of Rongbin since established.

 

  ● Inner Mongolia Chengheng Health Consulting Company Limited (“Chengheng”), a privately held Limited Company registered in Inner Mongolia, China on April 9, 2021. Longduoduo Health Technology has controlled 80% of the ownership of Chengheng since established.

 

  ● Inner Mongolia Tianju Health Consulting Company Limited (“Tianju”), a privately held Limited Company registered in Inner Mongolia, China on July 5, 2021. Longduoduo Health Technology has controlled 51% of the ownership of Tianju since established.

 

The transactions summarized above are treated in the Company’s financial statements as a corporate restructuring (reorganization) of entities under common control, as each of the eleven entities have at all times been under the control of Mr. Zhang Liang. Therefore, in accordance with ASC 805-50-45-5, the current capital structure has been retroactively presented in prior periods as if such structure existed at that time, and the entities under common control are presented on a combined basis for all periods. Since all of the subsidiaries were under common control for all periods presented, the results of these subsidiaries are included in the Company’s financial statements for all periods presented.

 

F-5

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

(UNAUDITED)

 

NOTE 2. GOING CONCERN

 

The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis. No adjustments have been made to the carrying amounts or classification of assets and liabilities that would result from the outcome of the uncertainty described below.

 

In accordance with ASC 205-40, Presentation of Financial Statements - Going Concern, management evaluated whether conditions and events in the aggregate raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued.

 

As of September 30, 2026, the Company had cash and cash equivalents of $1,006,499. For the three months ended September 30, 2026, the Company reported a net loss of $474,167 and net cash used in operating activities of $615,031. The material decline in commission revenue has resulted in ongoing operating losses and negative operating cash flows. Based on current operating levels and projected cash requirements over the twelve-month assessment period, existing cash resources are not sufficient to fund operations and meet obligations as they come due. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

 

Management is pursuing remedial actions to improve liquidity, including expanding new product sales, implementing further expense optimization to reduce recurring cash burn, and seeking potential financial support from the majority shareholder as needed. The Company’s ability to continue as a going concern depends on successful execution of these plans, generation of sufficient operating cash flows, and securing of additional financing, none of which can be assured.

 

Accordingly, management has concluded that substantial doubt about the Company’s ability to continue as a going concern exists.

 

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

A. Basis of presentation

 

The accompanying consolidated financial statements are expressed in U.S. Dollars and have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

B. Principles of consolidation

 

The consolidated financial statements include the accounts of Longduoduo and its subsidiaries. All significant inter-company accounts and transactions have been eliminated. The consolidated financial statements include 100% of assets, liabilities, and net income or loss of these subsidiaries.

 

LDD Technology Limited was established on March 18, 2024 under the laws of British Virgin Islands. LDD is a holding company with no business operations of its own. On February 19, 2025, Longduoduo issued 10,020 shares of its common stock to the original shareholders of LDD, and assumed all the original shareholders’ capital contribution obligations to LDD, in exchange for 100% of the outstanding shares of LDD. This transaction is treated in the Company’s financial statements as a corporate restructuring (reorganization) of entities under common control, as LDD and Longduoduo have at all times been under the control of Mr. Zhang Liang. Therefore, this transaction is accounted for by the carry-over basis method (also referred to as the pooling-of-interests method or historical-cost method). The assets and liabilities transferred are recorded by the receiving entity at their historical carrying amounts in the consolidated financial statements of the controlling parent, not at fair value. No new goodwill is recognized, and no gain or loss is recorded. In accordance with ASC 805-50-45-5, the current capital structure has been retroactively presented in prior periods as if such structure existed at that time, and the entities under common control are presented on a combined basis for all periods. Since LDD and Longduoduo were under common control for all periods presented, the results of LDD are included in the Company’s financial statements for all periods presented.

 

Longduoduo’s subsidiaries as of September 30, 2026 are listed as follows:

 

Name     Place of
Incorporation
    Attributable
equity
interest %
    Authorized
capital
 
LDD Technology Limited     British Virgin Islands       100     US$ 100,000  
LDDJK Hong Kong Limited     Hong Kong       100     HK$ 10,000  
Beijing Julong Health Consulting Co., Limited     China       100       0  
Beijing Yihua Health Consulting Co., Limited     China       100       0  
Longduoduo Health Technology Company Limited     China       100       0  
Inner Mongolia Qingguo Health Consulting Company Limited     China       90       0  
Inner Mongolia Rongbin Health Consulting Company Limited     China       80       0  
Inner Mongolia Chengheng Health Consulting Company Limited     China       80       0  
Inner Mongolia Tianju Health Consulting Company Limited     China       51       0  

  

F-6

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

C. Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however, actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the inventory valuation allowance and the treatment of the shares issued. These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable. Actual results could differ from these estimates.

 

D. Functional currency and foreign currency translation

 

An entity’s functional currency is the currency of the primary economic environment in which it operates, normally that is the currency of the environment in which the entity primarily generates and expends cash. Management’s judgment is essential to determine the functional currency by assessing various indicators, such as cash flows, sales price and market, expenses, financing and inter-company transactions and arrangements. The functional currency of the Company is the Chinese Renminbi (“RMB”), except the functional currency of Longduoduo HK and LDDJK is the Hong Kong Dollar and the functional currency of Longduoduo and LDD is the United States Dollar (“US Dollars” or “$”). The reporting currency of these consolidated financial statements is in US Dollars.

 

The financial statements of Longduoduo’s subsidiaries, which are prepared using the RMB and HKD, are translated into the Company’s reporting currency, the US Dollar. Assets and liabilities are translated using the exchange rate at each reporting period end date. Revenue and expenses are translated using weighted average rates prevailing during each reporting period, and stockholders’ equity is translated at historical exchange rates. Adjustments resulting from the translation are recorded as a separate component of accumulated other comprehensive income or expense.

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transactions. Foreign currency exchange gains and losses resulting from these transactions are included in operations.

 

The exchange rates used for foreign currency translation are as follows:

 

        For the Three Months Ended September 30,  
        2026     2025  
        (USD to RMB/
USD to HKD)
    (USD to RMB/
USD to HKD)
 
Assets and liabilities   period end exchange rate     6.7041/7.8463       7.1203/7.7813  
Revenue and expenses   period weighted average     6.7419/7.8423       7.1572/7.8208  

 

E. Concentration of credit risk

 

The Company maintains cash in banks in China and the United States. In China, the insurance coverage of each bank is RMB500,000 (approximately USD$75,000). As of September 30, 2026 and June 30, 2026, the Company had $485,245 and $949,475 cash in excess of the insured amount, respectively. In the United States, deposit insurance coverage is limited to USD250,000 per bank. As of September 30, 2026 and June 30, 2026, the Company maintained no cash balances in excess of these insured limits.

 

For the three months ended September 30, 2026 and 2025, we had a single customer for our agent sales, whose revenue represented 100% and 99.1% of total revenue, respectively.

 

F-7

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

For the three months ended September 30, 2026 and 2025, the Company had nil and two major suppliers for our service revenue, each of which accounted for over 10% of the Company’s total cost of revenue.

 

    For three months ended
September 30,
2026
    For three months ended
September 30,
2025
 
    Cost of
revenue
    Percentage
of Cost of
revenue
    Cost of
revenue
    Percentage
of Cost of
revenue
 
                         
Supplier A   $ N/A       N/A     $ 3,395       51 %
Supplier B     N/A       N/A       753       11 %

 

As of September 30, 2026 and 2025, the Company had one and two major suppliers that each accounted for over 10% of its total accounts payable.

 

    As of
September 30,
2026
    As of
June 30,
2026
 
    Account
payable
    Percentage
of Accounts
payable
    Account
payable
    Percentage
of Accounts
payable
 
Supplier C   $ 166,127       71 %   $ 179,566       45 %
Supplier D     N/A       N/A       155,837       39 %

 

F. Cash and cash equivalents

 

Cash consists of cash on hand and bank deposits, which are unrestricted as to withdrawal and use. All highly liquid investments with original stated maturity of three months or less are classified as cash and cash equivalents. Cash equivalents approximate or equal fair value due to their short-term nature. The Company’s cash and cash equivalents consist of cash on hand and cash in bank as of September 30, 2026 and June 30, 2026.

 

G. Property and equipment

 

Property and equipment are stated at cost. Expenditures for maintenance and repairs are charged to operations when incurred, while additions and betterments are capitalized. Depreciation is recorded on a straight-line basis over the useful lives of the assets. When assets are retired or disposed, the asset’s original cost and related accumulated depreciation are eliminated from those accounts and any gain or loss is reflected in income.

 

The Company capitalizes certain costs associated with the acquisition of software. Once the software is ready for its intended use, these costs are amortized on a straight-line basis over the software’s expected useful life.

 

F-8

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

The estimated useful lives for property and equipment categories are as follows:

 

Office equipment and furniture     3 years  
Leasehold Improvements     1-5 years  

 

H. Intangible Assets

 

Intangible assets consist of software. Intangible assets are initially recognized at their respective acquisition costs. All of the Company’s intangible assets have been determined to have finite useful lives and are, therefore, amortized using the straight-line method over their estimated useful lives:

 

Software     3 years  

 

I. Fair value measurements

 

The Company applies the provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Section 820, Fair Value Measurements (“ASC 820”), for fair value measurements of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed at fair value in the financial statements. ASC 820 also establishes a framework for measuring fair value and expands disclosures about fair value measurements.

 

Fair value is defined as the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In determining the fair value for the assets and liabilities required or permitted to be recorded, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.

 

ASC 820 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes three levels of inputs that may be used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:

 

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

 

Level 2: Quoted prices, other than those in Level 1, in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability,

 

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

 

There were no transfers between level 1, level 2 or level 3 measurements during the three months ended September 30, 2026 and 2025.

 

Financial assets and liabilities of the Company consisted primarily of cash and cash equivalents, other receivables, accounts payable, accrued expenses, due to related parties and other current liabilities. As of September 30, 2026 and June 30, 2026, the carrying values of these financial instruments approximated their fair values due to the short-term maturity of these instruments.

 

F-9

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

J. Segment information and geographic data

 

The Company is operating in one segment in accordance with the accounting guidance in FASB ASC Topic 280, Segment Reporting. The Company’s revenues are from customers in the People’s Republic of China (“PRC”). Substantially all assets of the Company are located in the PRC.

 

K. Revenue recognition

 

The Company adopted FASB ASC Section 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the sales of products and services by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.

 

The Company recognizes revenue when the amount of revenue can be reliably measured, it is probable that economic benefits will flow to the entity, and specific criteria have been met for each of the Company’s activities as described below.

 

Service Revenue

  

The Company sells healthcare service packages to customers, which represent the rights to services purchased by the Company. The delivery of a healthcare service package to a customer represents a separate performance obligation. The Company’s policy is to recognize service revenue at that time when delivery of the healthcare service package has been contracted for, ownership and risk of loss have been transferred to the customer, and the service has been provided. Accordingly, revenue is recognized at the point in time when the service is provided. Service revenue is recognized when the healthcare service package has been delivered to the customer and there are no remaining performance obligations.

 

Management regularly reviews the sales returns and allowances based on historical experience. Any subsequent sales returns and cancellations are recognized upon notification from the customers. The liability for sales returns and allowances relating to the sale of healthcare service packages amounted to $nil and $66 as of September 30, 2026 and June 30, 2026, respectively. Management’s provision for sales returns and allowances was nil and 1.65%, respectively, of the total service revenue for the three months ended September 30, 2026 and 2025.

 

The Company typically collects fees before delivery of healthcare packages. Amounts received from a customer before the delivery of the healthcare package are recorded as deferred revenue on the Consolidated Balance Sheets.

 

Commission Revenue

 

Commencing in the three months ended June 30, 2023, the Company started offering in a sales agent capacity healthcare service and product packages of a third-party provider. The third party is responsible for fulfillment of the services to the customer and the Company has no performance commitment or liability to the customer. The Company receives deposits from the customers, which are recorded as deferred revenue on the consolidated balance sheets. The Company then remits to the third-party provider the provider’s contracted amounts, and retains the remaining amounts as commission revenue. The commission revenue is recognized upon acceptance of the customer contract by the third-party provider and is presented on a net basis in the Statement of Operations and Comprehensive Loss.

 

Cost of Revenues

 

Cost of service revenue consists primarily of the cost of healthcare service packages purchased from third party healthcare service providers to fulfill contracts with customers.

 

F-10

  

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

L. Income taxes

 

The Company follows FASB ASC Section 740, Income Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740-10-30 requires income tax positions to meet a more-likely-than-not recognition threshold to be recognized in the financial statements. Under ASC 740-10-30, tax positions that previously failed to meet the more-likely-than-not threshold should be recognized in the first subsequent financial reporting period in which that threshold is met.

 

The application of tax laws and regulations is subject to legal and factual interpretation, judgment and uncertainty. Tax laws and regulations themselves are subject to change as a result of changes in fiscal policy, changes in legislation, the evolution of regulations and court rulings. Therefore, the actual liability may be materially different from our estimates, which could result in the need to record additional tax liabilities or potentially reverse previously recorded tax liabilities or the deferred tax asset valuation allowance.

 

As a result of the implementation of ASC 740-10, the Company made a comprehensive review of its portfolio of tax positions in accordance with recognition standards established by ASC 740-10. The Company recognized no material adjustments to liabilities or shareholder’s equity as a result of the implementation.

 

M. Earnings (loss) per share

 

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, Earnings Per Share. ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as net income (loss) divided by the weighted average common shares outstanding during the period.

 

Diluted EPS is similar to basic EPS but presents the dilutive effect on a per share basis of contracts to issue common shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. The computation of diluted EPS includes the estimated impact of the exercise of contracts to purchase common stock using the treasury stock method and the potential shares of converted common stock associated with the convertible debt using the if-converted method. Potential common shares that have an anti-dilutive effect (i.e., those that increase earnings per share or decrease loss per share) are excluded from the calculation of diluted EPS. 

  

N. Recently adopted accounting pronouncements

 

We do not believe that any recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial position, statements of operations and cash flows.

 

NOTE 4. PREPAYMENTS

 

Prepayments primarily include prepaid expenses, lease payments and advance to suppliers. As of September 30, 2026 and June 30, 2026, prepayments and deferred expenses were $209,375 and $138,287, respectively.

 

F-11

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

NOTE 5. PROPERTY AND EQUIPMENT

 

At September 30, 2026 and June 30, 2026, property and equipment, at cost, consisted of:

 

    September 30,     June 30,  
    2026     2026  
             
Office equipment and furniture   $ 491,798     $ 485,397  
Leasehold improvement     47,881       47,258  
Total     539,679       532,655  
Accumulated depreciation     351,928       319,630  
Total property and equipment, net   $ 187,751     $ 213,025  

 

The Company recorded depreciation and amortization expense of $27,926 for the three months ended September 30, 2026, of which $27,926 was recorded as operating expense.

 

The Company recorded depreciation and amortization expense of $27,422 for the three months ended September 30, 2025, of which $24,978 was recorded as operating expense and $2,444 was recorded as cost of revenue.

 

The Company disposed of fully depreciated assets with a total value of $14,044 for the three months ended September 30, 2025.

 

NOTE 6. RELATED PARTY TRANSACTIONS

 

Due to related parties

 

Due to related parties consists of the following:

 

Name of related party   September 30,
2026
    June 30,
2026
 
Zhang Liang   $ 409     $ 409  
Xu Huibo     4,475       3,312  
Total   $ 4,884     $ 3,721  

 

Mr. Zhang Liang controls approximately 51.3% of Longduoduo’s issued and outstanding common stock. These advances due to related parties are unsecured, repayable on demand, and bear no interest.

 

Xu Huibo is the President and Chairman of the Company. These advances due to related parties are unsecured, repayable on demand, and bear no interest.

 

NOTE 7. INCOME TAXES

 

United States

 

Longduoduo is subject to the U.S. corporation tax rate of 21%.

 

British Virgin Islands

 

The Company’s subsidiary, LDD, is incorporated in the BVI and is not subject to tax on income or capital gain. In addition, payments of dividends by LDD to its shareholders are not subject to withholding tax in the BVI.

 

F-12

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

Hong Kong

 

Longduoduo HK and LDDJK were incorporated in Hong Kong; Longduoduo HK deregistered on August 28, 2026; LDDJK remains incorporated in Hong Kong.

 

During the periods when they were incorporated in Hong Kong, each of Longduoduo HK and LDDJK was subject to Hong Kong profits tax. Each of them was subject to Hong Kong taxation on its activities conducted in Hong Kong and income arising in or derived from Hong Kong. From the year of assessment, 2019/2020, onwards, Hong Kong profits tax rates have been 8.25% on assessable profits up to HK$2,000,000, and 16.5% on any part of assessable profits over HK$2,000,000. The Company did not have any income subject to the Hong Kong profits tax.

 

China

 

Julong and its subsidiaries are subject to a 25% standard enterprise income tax in the PRC. If the taxable income in the calendar year does not exceed RMB 3 million, only 25% of the taxable income will be included in the tax base, which is then subject to a preferential tax rate of 20%. The Company recognized a $4,678 income tax benefit (tax refund) and $67,094 of PRC income tax expense to the Mainland China tax authority for the three months ended September 30, 2026 and 2025, of which $62,690 incurred by Longduoduo HK for the three months ended September 30, 2025 was income tax to the Mainland China tax authority in connection with the transfer of its subsidiary, Longduoduo Health Technology, to Julong.

 

A summary of income (loss) before income taxes for domestic and foreign locations for the three months ended September 30, 2026 and 2025 is as follows:

 

    For the three months ended
September 30,
 
    2026     2025  
United States   $ (78,982 )   $ (96,986 )
Foreign     (399,863 )     52,898  
Loss before income taxes   $ (478,845 )   $ (44,088 )

 

The difference between the U.S. federal statutory income tax rate and the Company’s effective tax rate was as follows:

 

    For the three months ended
September 30,
 
    2026     2025  
Income tax (benefit) at USA statutory rate     21 %     21 %
U.S. valuation allowance     (21 )%     (21 )%
Income tax (benefit) at USA effective rate     0 %     0 %

 

The difference between the PRC statutory income tax rate and the PRC effective tax rate was as follows:

 

    For the Three Months Ended
September 30,
 
    2026     2025  
Income tax (benefit) at PRC statutory rate     25 %     25 %
Tax preference     (1 )%     (28 )%
PRC valuation allowance     (23 )%     11 %
Income tax (benefit) at PRC effective rate     1 %     8 %

 

F-13

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

Additionally, $62,690 incurred by Longduoduo HK for the three months ended September 30, 2025, was income tax to the Mainland China tax authority in connection with the transfer of its subsidiary Longduoduo Health Technology to Julong.

 

The Company did not recognize deferred tax assets since it is not more likely than not that it will realize such deferred taxes. The deferred tax would apply to Longduoduo in the U.S. and Julong and subsidiaries in China.

 

As of September 30, 2026, Julong and its subsidiaries had total net operating loss carry forwards of approximately $1,021,113 in the PRC that expire through 2031. Due to the uncertainty of utilizing these carry forwards, the Company provided a 100% allowance on all deferred tax assets, approximately $255,278 and $220,337, related to its operations in the PRC as of September 30, 2026 and June 30, 2026, respectively. The PRC valuation allowance has increased by $34,941 and $30,149 for the three months ended September 30, 2026 and 2025, respectively.

 

The Company had net operating loss carryforwards from its United States operations of approximately $1,488,419 as of September 30, 2026. The Company’s United States operations consist solely of ownership of its foreign subsidiaries, and the losses arise from administration expenses. Accordingly, management provided a 100% valuation allowance of approximately $312,568 and $295,982 against the deferred tax assets related to the Company’s United States operations as of September 30, 2026 and June 30, 2026, respectively, because the deferred tax benefits of the net operating loss carry forwards in the United States are not likely to be utilized. The US valuation allowance has increased by approximately $16,586 and $20,367 for the three months ended September 30, 2026 and 2025, respectively.

 

The Company is subject to examination by the Internal Revenue Service (IRS) in the United States as well as by the taxing authorities in China, where the Company has significant business operations. The table below presents the earliest tax year that remains subject to examination by major jurisdiction. 

 

    Earliest tax year that
remains subject to examination
U.S. Federal   June 30, 2021
China   June 30, 2021

 

NOTE 8. LEASES

 

On April 1 of 2024, Tianju leased office space (approximately 595 square meters) under an operating lease agreement with Han Ruijun. Under the terms of the agreement, Tianju is committed to make lease payments of approximately $19,000 (RMB137,000) annually for the period between April 1, 2024 and March 31, 2027.

 

On August 14, 2024, Qingguo leased office space (approximately 482 square meters) under an operating lease agreement with Inner Mongolia Chuangfuhui Enterprise Management Co., Ltd. Under the terms of the agreement, Qingguo was committed to make lease payments of approximately $30,700 (RMB 220,000) for the period between September 10, 2024 and September 10, 2025. Inner Mongolia Chuangfuhui Enterprise Management Co., Ltd, acting as the tenant of the property owner Chen Mingyue, sublet the property to Qingguo. Subsequently, on September 19, 2025, Qingguo entered into a non-cancellable operating lease agreement directly with Chen Mingyue for the same office space. Under terms of the lease agreement, from September 10, 2025, Qingguo was committed to make lease payments totaling approximately $30,898 (RMB 220,000) per year for 1 year. On September 18, 2026, the Company renewed the lease agreement with Chen Mingyue. Under the renewed terms, the Company is obligated to make annual lease payments totaling approximately $32,400 (RMB 220,000) for a one-year term commencing on September 10, 2026.

 

F-14

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

On November 20, 2024, Chengheng leased an office space (approximately 611 square meters) under an operating lease agreement from Dongsheng District Baiyan Health Consultation Department. Under the terms of the agreement, Chengheng was committed to make lease payments of approximately $16,700 (RMB120,000) for the period between November 20, 2024 and November 20, 2025. The office lease was not renewed upon expiration.

 

On March 11 of 2025, Longduoduo Health Technology leased office space (approximately 150 square meters) under an operating lease agreement with Liu Libao. Under the terms of the agreement, Longduoduo Health Technology was committed to make lease payments of approximately $4,200 (RMB30,000) for the period between March 11, 2025 and March 10, 2026. On March 11, 2026, Longduoduo Health Technology renewed the lease agreement with Liu Liqiang, who, together with his brother Liu Libao, serves as a co-landlord of the leased premises. Under terms of the lease agreement, from March 11, 2026, Longduoduo Health Technology is committed to make lease payment totalling approximately $3,621 (RMB25,000) per year for 1 year.

 

On August 8, 2025, Chengheng leased an office space (approximately 400 square meters) under an operating lease agreement from Pan Jirong and Zhong Jing. Under terms of the lease agreement, from August 8, 2025 to August 7, 2028, Chengheng is committed to make lease payments of approximately $24,000 (RMB 170,000) per year for 3 years.

 

On July 20, 2025, Rongbin leased office space (approximately 97.73 square meters) under an operating lease agreement with Han Yuefei. Under the terms of the agreement, Rongbin was committed to make lease payments of $1,685 (RMB 12,000) per year for the period between July 20, 2025 and July 19, 2026. On August 20, 2026, the Company renewed the lease agreement with Han Yuefei. Under the renewed terms, the Company is obligated to make annual lease payments totaling approximately $1,685 (RMB 12,000) for a one-year term commencing on July 20, 2026.

 

On August 20, 2025, Rongbin leased office space (approximately 626.38 square meters) under an operating lease agreement with Inner Mongolia Baogang Jinmao Real Estate Development Co., Ltd. Under the terms of the agreement, Rongbin was committed to make lease payments of approximately $14,000 (RMB 100,320) per year for the period between September 1, 2025 and August 31, 2026. Rongbin renewed the agreement. Under terms of the lease agreement, from September 1, 2026 to October 6, 2027, Rongbin is committed to make lease payment of approximately $14,000 (RMB100,320) per year.

 

Leases with an initial term of 12 months or less are not recorded on the balance sheet. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in selling, general and administrative expenses. For lease agreements entered into or reassessed after the adoption of Topic 842, the Company did not combine lease and non-lease components.

 

Most leases do not include options to renew. The exercise of lease renewal options has to be agreed to by the lessors. The depreciable life of assets and leasehold improvements are limited by the term of leases, unless there is a transfer of title or purchase option reasonably certain of exercise. Lease expense is recognized on a straight-line basis over the term of the lease. Lease expense related to noncancelable operating leases was $24,457 and $23,604 for the three months ended September 30, 2026 and 2025, respectively.

 

F-15

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

Balance sheet information related to the Company’s leases is presented below:

 

    September 30,
2026
    June 30,
2026
 
Assets            
Operating lease right of use assets   $ 55,992     $ 66,283  
Liabilities                
Operating lease liabilities – current   $ 24,643     $ 24,113  
Operating lease liabilities – non-current     25,358       24,957  
Total Operating lease liabilities   $ 50,001     $ 49,070  

 

As most of the Company’s leases do not provide an implicit rate, the Company uses the 1-5 years borrowing rates from its bank, i.e. 3.5% and 3.95%, based on the information available at the commencement date in determining the present value of lease payments.

 

Maturities of lease liabilities are as follows:

 

For the years ending September 30:      
2027   $ 25,358  
2028     25,358  
Total lease payments     50,716  
Less: imputed interest     (715 )
Total lease liabilities   $ 50,001  

 

NOTE 9. CONTINGENCIES

 

Contingencies

 

Certain conditions may exist as of the date the consolidated financial statements are issued which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed.

 

Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

The Company was not subject to any material loss contingency as of September 30, 2026 and June 30, 2026. 

 

F-16

 

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND SEPTEMBER 30, 2025

(UNAUDITED)

 

NOTE 10. BASIC AND DILUTED EARNINGS PER SHARE

 

Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares comprise shares issuable upon the exercise of share-based awards, using the treasury stock method. The reconciliation of the numerators and denominators of the basic and diluted earnings per share computations is shown as follows:

 

    For the three months ended
September 30,
 
    2026     2025  
Numerator:            
Net loss attributable to common stockholders   $ (436,962 )   $ (90,954 )
Denominator:                
Basic and diluted weighted-average number of shares outstanding     30,015,036       30,015,036  
Net loss per share:                
Basic and diluted   $ (0.015 )   $ (0.003 )

 

NOTE 11. NON-CONTROLLING INTERESTS

 

Qingguo, Chengheng, Rongbin and Tianju are the Company’s majority-owned subsidiaries which are consolidated in the Company’s financial statements with non-controlling interests recognized. As of September 30, 2026, the Company held 90%, 80%, 80% and 51% interest in Qingguo, Chengheng, Rongbin and Tianju, respectively.

 

As of September 30, 2026 and June 30, 2026, the values of the non-controlling interests in the consolidated balance sheet were $15,346 and $52,074, respectively.

 

For the three months ended September 30, 2026, the comprehensive loss attributable to common stockholders and non-controlling interests were $416,290 and $36,728, respectively.

 

For the three months ended September 30, 2025, the comprehensive loss attributable to common stockholders and non-controlling interests were $77,697 and $19,599, respectively.

 

NOTE 12. SUBSEQUENT EVENTS

 

Management has evaluated subsequent events through the date which the consolidated financial statements were available to be issued. There are no subsequent events that require disclosure in accordance with FASB ASC Topic 855, “Subsequent Events.”

 

F-17

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Application of Critical Accounting Policies

 

The discussion and analysis of the Company’s financial condition and results of operations is based upon its condensed consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles. The preparation of these financial statements requires us to make significant estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These items are monitored and analyzed by management for changes in facts and circumstances, and material changes in these estimates could occur in the future. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from our estimates if past experience or other assumptions do not turn out to be substantially accurate.

 

In connection with the preparation of our financial statements for the three months ended September 30, 2026, there was no accounting estimate made which was (a) subject to a high degree of uncertainty and (b) material to our results.

 

Results of Operations

 

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

 

The following table shows key components of the unaudited results of operations during the three months ended September 30, 2026 and 2025: 

 

    For the Three Months Ended        
    September 30,        
    2026     2025     Change  
    (Unaudited)     (Unaudited)     $     %  
Total revenue   $ 17,595     $ 658,764     $ (641,169 )     (97 )%
Cost of revenue     -       6,710       (6,710 )     (100 )%
Gross Profit     17,595       652,054       (634,459 )     (97 )%
Total operating expenses     513,930       736,468       (222,538 )     (30 )%
Loss from operations     (496,335 )     (84,414 )     (411,921 )     488 %
Other income, net     17,490       40,326       (22,836 )     (57 )%
Loss before income taxes     (478,845 )     (44,088 )     (434,757 )     986 %
Income tax (benefit) expenses     (4,678 )     67,094       (71,772 )     (107 )%
Net loss   $ (474,167 )   $ (111,182 )   $ (362,985 )     326 %

 

During the three months ended September 30, 2026, we reported total revenue of $17,595 related to our agency services for Inner Mongolia Honghai Health Management Co., Ltd. (“Honghai”). In June of 2023, the Company began to engage in the sales agent business and focused on the sales of preventive healthcare & wellness solutions administered by Honghai, with whom we have a Sales Agency Agreement. As of September 30, 2026, we operate through five entities: Longduoduo Health Technology, Tianju, Qingguo, Rongbin and Chengheng, which are established in Huhhot, Ulanqab, Huhhot, Baotou and Ordos, respectively, which include four of the largest cities in Inner Mongolia, China.

 

Period to period revenue fell by 97% as compared with the operating revenue of $658,764 for the three months ended September 30, 2025. This decline was primarily attributable to the sales agent business. One important factor influencing revenue in the recent years is the impact of the economic environment. The prevailing economic environment, characterized by waning confidence in economic prospects, has compelled consumers to adopt significantly more cautious spending behavior, curtailing discretionary expenditures on preventive healthcare & wellness services and physical examinations. Management believes that the government has recently introduced policies to promote economic recovery, but it may take some time for the situation to truly improve. Meanwhile, as we wait for the economy to revive, the Company is implementing plans to improve its operations by adjusting its operational policies. 

 

Furthermore, the Company is currently undergoing a strategic transition, with its core business gradually shifting towards gut microbiota-based products. However, sales momentum has slowed as the new product portfolio has yet to gain significant market traction, and market acceptance for the newly launched packages remains limited.

 

Cost of revenue relates solely to our healthcare service revenue, and mainly consists of our payments to the third-party healthcare service providers who perform healthcare services for our customers. During the three months ended September 30, 2026, the Company did not recognize any revenue or cost of revenue from principal arrangements. By comparison, our gross loss from service revenue for the three months ended September 30, 2025 was $1,104. As the total service revenue is minimal, profit turns negative due to fixed depreciation.

 

2

  

For the three months ended September 30, 2026, we achieved gross profit of $17,595. However, we realized a loss from operations of $496,335 for the three months ended September 30, 2026 because the Company incurred high fixed costs including staff costs and office expenses. Our operating expenses consist primarily of salaries and benefits, office expenses, professional fees and depreciation and amortization. Our operating expenses in the period ended September 30, 2026 decreased by $222,538, primarily attributable to:

 

  ● $86,717 in advertising and promotion expenses incurred in the three months ended September 30, 2026, compared to $314,481 recorded in the three months ended September 30, 2025. This decrease in advertising and promotion expenses is due to lower sales.

 

  ● $84,788 in professional fees in the three months ended September 30, 2026, compared to $93,254 recorded in the three months ended September 30, 2025. In both cases, the expense was primarily related to the costs incurred by the Company to establish and sustain its status as an SEC-reporting company in the United States.

 

  ● $138,763 in salaries and benefits expenses in the three months ended September 30, 2026, compared to $135,429 in the three months ended September 30, 2025.

 

  ● $151,279 in office expenses in the three months ended September 30, 2026, compared to $144,722 in the three months ended September 30, 2025.  Office expenses mainly consist of entertainment expenses, business consulting fees, vehicle usage costs, social security contributions, travel expenses, and other office maintenance-related expenses.

 

Our net loss for the three months ended September 30, 2026 was $474,167, compared to a net loss of $111,182 in the three months ended September 30, 2025.

 

Our reporting currency is the U.S. dollar. Our functional currency is the local currency, which is the Renminbi (RMB) for our Chinese subsidiaries, the Hong Kong Dollar (HKD) for our Hong Kong subsidiaries, and the U.S. Dollar (USD) for our BVI subsidiary. Results of operations and cash flow for RMB and HKD are translated at average exchange rates during the period being reported upon, and assets and liabilities are translated at the unified exchange rate as quoted by OANDA on the balance sheet date. Translation adjustments resulting from this process are included in other comprehensive income (loss). For the three months ended September 30, 2026 and 2025, foreign currency translation adjustments of $21,149 and $13,886, respectively, have been reported as other comprehensive income in the consolidated statement of operations and comprehensive loss.

 

Liquidity and Capital Resources

 

As of September 30, 2026, the Company held $1,006,499 in cash and cash equivalents, yet working capital was only $85,068. This divergence primarily reflects our use of customer prepayments to fund operations. Of the $893,991 in deferred revenue recorded on the balance sheet as of September 30, 2026, the majority was utilized to cover ongoing operating expenses, leaving $209,375 in prepayments on the balance sheet. Going forward, we will strive to achieve a better balance of customer deposits and prepayments; but we will achieve that better balance only when profits from operations and funds from financing are adequate to support the expansion effort that will be necessary for successful operations.

 

Going Concern Consideration

 

In accordance with ASC 205-40, management has evaluated the Company’s ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued. As of September 30, 2026, the Company had cash and cash equivalents of $1,006,499, and reported a net loss of $474,167 and net cash used in operating activities of $615,031 for the three months then ended, primarily due to the material decline in commission revenue. Based on current projections, existing cash resources are insufficient to fund operations and satisfy obligations as they become due over the assessment period.

 

Management is pursuing remedial actions including new product expansion, further cost optimization, and potential financial support from the majority shareholder. The Company’s ability to continue as a going concern depends on successful execution of these plans, generation of sufficient operating cash flows, and securing of additional financing, none of which can be assured. Accordingly, substantial doubt about the Company’s ability to continue as a going concern exists.

 

3

 

Cash Flows

 

The following unaudited table summarizes our cash flows for the three months ended September 30, 2026 and 2025.

 

    For the Three Months Ended
September 30,
       
    2026     2025        
    (Unaudited)     (Unaudited)     Change  
Net cash used in operating activities   $ (615,031 )   $ (374,184 )   $ (240,847 )
Net cash used in investing activities     -       (29,948 )     29,948  
Effect of exchange rate fluctuation on cash and cash equivalents     32,600       8,707       23,893  
Net decrease in cash and cash equivalents     (582,431 )     (395,425 )     (187,006 )
Cash and cash equivalents, beginning of period     1,588,930       1,642,721       (53,791 )
Cash and cash equivalents, end of period   $ 1,006,499     $ 1,247,296     $ (240,797 )

 

Net Cash Used in Operating Activities

 

For the three months ended September 30, 2026, operating activities used $615,031 in cash, compared with $374,184 of cash used in operating activities in the three months ended September 30, 2025. The net cash used in operating activities during the three months ended September 30, 2026, was primarily attributable to a net loss of $474,167, a cash outflow of $174,874 from the settlement of accounts payable, partially offset by a cash inflow of $92,617 from deferred revenue and a cash outflow of $70,187 from prepayments.

 

Net Cash Used in Investing Activities

 

Net cash used in investing activities for the three months ended September 30, 2026 was $nil, compared to $29,948 for the three months ended September 30, 2025. In the three months ended September 30, 2025, the cash was used for the purchase of fixed assets and office decoration.

  

Trends, Events and Uncertainties

 

The U.S. government, including the SEC, has made statements and taken actions that have led to changes in relations between the U.S. and China, and will impact companies with connections to the United States or China. Those actions by the U.S. government included imposing several rounds of tariffs affecting certain products manufactured in China and imposing sanctions and restrictions in relation to China. Actions by the SEC included issuing statements indicating that it would make enhanced review of companies with significant China-based operations. It is unknown whether and to what extent new legislation, executive orders, tariffs, laws or regulations will be adopted, or the effect that any such actions would have on U.S.-domiciled companies with significant connections to China, our industry or on us. Any unfavorable government policies on cross-border relations, including increased scrutiny on companies with significant China-based operations, capital controls or tariffs, may affect our ability to raise capital and the market price of our shares. If any new legislation, executive orders, tariffs, laws and/or regulations are implemented, if existing trade agreements are renegotiated or if the U.S. or Chinese governments take retaliatory actions due to the recent U.S.-China tensions, such changes could have an adverse effect on our business, financial condition and results of operations, our ability to raise capital and the market price of our shares. Changes in United States and China relations and/or regulations may adversely impact our business, our operating results, our ability to raise capital and the market price of our shares.

 

Other than the factors listed above we do not know of any trends, events or uncertainties that have had or are reasonably expected to have a material impact on our net sales or revenues or income from continuing operations. 

 

4

 

Recent Accounting Pronouncements

 

There were no recent accounting pronouncements that we expect to have a material effect on the Company’s financial position or results of operations.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not applicable.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Our management maintains disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to provide reasonable assurance that the material information required to be disclosed by us in our periodic reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.

 

Under the supervision and with the participation of our management team, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended, as of September 30, 2026. Based on this evaluation, we concluded that our disclosure controls and procedures have the following material weaknesses:

 

  ● The relatively small number of employees who are responsible for accounting functions prevents us from segregating duties within our internal control system.

 

  ● Our internal financial staff lack expertise in identifying and addressing complex accounting issues under U.S. Generally Accepted Accounting Principles.

 

  ● Our Chief Financial Officer is not familiar with the accounting and reporting requirements of a U.S. public company.

 

  ● We have not developed sufficient documentation concerning our existing financial processes, risk assessment and internal controls.

 

Based on their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the Company’s system of disclosure controls and procedures was not effective as of September 30, 2026 for the purposes described in this paragraph.

 

Changes in Internal Control over Financial Reporting

 

During the period covered by this report, there has been no change in our internal control over financial reporting that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

 

5

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are not presently a party to any legal proceedings that, in the opinion of our management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows.

 

Item 1A. Risk Factors.

 

Except for the additional liquidity and going concern risk described below, there have been no material changes from the risk factors included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2026, as filed with the SEC on September 30, 2026.

 

We have incurred ongoing operating losses and negative operating cash flows. Management has concluded that substantial doubt exists about our ability to continue as a going concern. Our future liquidity depends on revenue recovery, cost savings and additional financing, none of which can be assured. Failure to secure sufficient capital could materially harm our business and financial condition.

 

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds.

 

During the quarter ended September 30, 2026, the Company did not complete any unregistered sales of equity securities that was not reported in a Current Report on Form 8-K.

 

The Company did not repurchase any of its equity securities that were registered under Section 12 of the Securities Act during the quarter ended September 30, 2026.

 

Item 3. Defaults upon Senior Securities.

 

Not applicable

 

Item 4. Mine Safety Disclosure

 

Not applicable.

 

Item 5. Other Information.

 

During the quarter ended September 30, 2026, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.

 

Item 6. Exhibits

 

INDEX TO EXHIBITS

 

Exhibit No.   Description of Exhibit
31.1   Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2   Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document.
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

6

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

LONGDUODUO COMPANY LIMITED

 

Signature   Title   Date
         
/s/ Zhou Hongxiao   Chief Executive Officer   November 16, 2026
Zhou Hongxiao   (Principal Executive Officer)    
         
/s/ Kang Liping   Chief Financial Officer   November 16, 2026
Kang Liping   (Principal Financial and Accounting Officer)    

 

 

7

 

Keep reading